ClinicalTrials.Veeva

Menu

Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation

L

LifeScan

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: Blood Glucose Monitoring System.

Study type

Interventional

Funder types

Industry

Identifiers

NCT02718703
3129822

Details and patient eligibility

About

Clinical Evaluation including System Accuracy, User Performance and System Use Evaluation of a new Blood Glucose Monitoring System.

Enrollment

34 patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Summary of Inclusion Criteria:

  • Able to voluntarily provide written informed consent to participate in the study.
  • User Performance Accuracy Testing Only: Self-Monitoring - Subject is currently performing unassisted self-monitoring of blood glucose.

Exclusion Criteria:

  • Female subjects who are pregnant or lactating.
  • Subjects who, in the opinion of the Investigator, are unsuitable for participation in the study.
  • User Performance Accuracy Testing Only -Prior involvement with the investigational BGMS being used in this study.

Trial design

34 participants in 1 patient group

Blood Glucose monitoring System (BGMS)
Experimental group
Description:
Intervention: Blood Glucose monitoring System (BGMS) Results obtained from the BGMS for UP and SA are compared to a reference instrument (YSI)
Treatment:
Device: Blood Glucose Monitoring System.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems